Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the audited Standalone and ....
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Biotech has informed exchanges that its Board of Directors will meet on May 29, 2026 to consider and approve the audited Standalone and Consolidated Financial Results for Q4 and the financial year ended March 31, 2026. The meeting will also consider recommending a final dividend on equity shares, subject to shareholder approval at the ensuing AGM. Additionally, the trading window remains closed for designated persons until 48 hours after the financial results are declared, consistent with SEBI's insider trading regulations.
This is a routine board meeting intimation. The scheduled meeting to approve FY2026 results and potential dividend announcement could positively influence investor sentiment if results meet expectations. The trading window closure indicates that insiders are restricted from trading until after the results are public.